Motor Cortex Stimulation as Treatment of Trigeminal Neuropathic Pain

Meyerson, Björn A.; Lindblom, Ulf; Linderoth, Bengt; Lind, Göran; Herregodts, Patrick

doi:10.1007/978-3-7091-9297-9_34

Cited by 149 publications

(184 citation statements)

References 8 publications

(2 reference statements)

Supporting

Mentioning

175

Contrasting

Unclassified

Order By: Relevance

“…Hardware failures and infection were the second and third most likely complications, respectively. Both Myerson et al 29 and Nguyen et al 66 reported hematomas, one of which was asymptomatic and the other required surgical intervention.…”

Section: Introductionmentioning

confidence: 99%

Motor Cortex Stimulation for Pain and Movement Disorders

Arle

Shils

2008

Neurotherapeutics

View full text Add to dashboard Cite

Summary:Since initial reports in the early 1990s, stimulation of the M1 region of the cortex (MCS) has been used to treat chronic refractory pain conditions and a variety of movement disorders. A Medline search of literature between 1991 and 2007 revealed 512 cases using MCS. Although most of these relate to the treatment of pain (422), 84 of them involve movement disorders. More recently, several studies have specifically looked at treating Parkinson's disease (PD) with MCS. We report here several of our own cases using MCS to treat poststroke and non-poststroke pain syndromes and movement disorders (n ϭ 8), PD (n ϭ 4), ET (n ϭ 2), and cortico-basal degeneration (n ϭ 1). We also cover the essential history of this procedure and our current research using computational modeling to understand further the underlying mechanisms of MCS.

show abstract

Section: Introductionmentioning

confidence: 99%

Motor Cortex Stimulation for Pain and Movement Disorders

Arle

Shils

2008

Neurotherapeutics

View full text Add to dashboard Cite

show abstract

“…Extrazerebrale neuromodulative Verfahren kommen auf verschiedenen Stimulationsebenen zur Anwendung: Rückenmark ("spinal cord stimulation"), Nervenwurzel ("nerve root stimulation"), Ganglion ("dorsal root ganglion stimulation"), peripherer Nerv, Ganglion trigeminale ("peripheral ganglion stimulation"; [25,26]) und subkutane Strukturen ("subcutaneous stimulation", transkutane elektrische Nervenstimulation; [27]). Intrazerebrale Verfahren zur Schmerzbeeinflussung, wie die tiefe Hirnstimulation ("deep brain stimulation"; [28,29]) oder die Motorkortexstimulation [30][31][32][33], wurden erst später entwickelt. …”

Section: » Neurochirurgische Verfahren Stellen Die Letzte Stufe Jederunclassified

Nichtmanuelle Schmerztherapie der Lenden-Becken-Hüft-Region

Eisner¹

2017

Manuelle Medizin

View full text Add to dashboard Cite

“…8,15,20) Excellent results have also been reported in the treatment of trigeminal neuropathic pain, with 75-100% of patients achieving pain relief. 6,13,14,18) A prospective study used MCS to treat 10 patients with neuropathic facial pain attributed to surgical trigeminal root injury, poststroke, postherpetic, or no cause. 3) Immediate pain relief was achieved in 88% of patients, with 75% pain relief at a mean follow-up period of 10 months.…”

Section: Tnmentioning

confidence: 99%

“…Central neuropathic pain can occur as sequelae of stroke. Multiple sclerosis (MS) occasionally manifests as neuropathic facial pain, and demyelination of the pontine trigeminal pathways can contribute the trigeminal neuropathic pain associated with MS. 10,16) Motor cortex stimulation (MCS) provides good pain relief for neuropathic facial pain, 3,6,13,18) although the effectiveness for neuropathic facial pain caused by MS remains unclear. We describe a case of neuropathic facial pain originating associated with MS which was successfully treated with MCS.…”

Section: Introductionmentioning

confidence: 99%

Motor Cortex Stimulation for Intractable Neuropathic Facial Pain Related to Multiple Sclerosis -Case Report-

Tanei

Kajita

Wakabayashi

2010

Neurol. Med. Chir.(Tokyo)

View full text Add to dashboard Cite

A 33-year-old man presented with ongoing severe right facial pain and sensory disturbances caused by multiple sclerosis (MS). Neuroimaging demonstrated demyelinating lesions in the right dorsal pons and medulla oblongata. The pain was refractory to carbamazepine at 800 mg/day, gabapentin at 1800 mg/day, morphine at 30 mg/day, amitriptyline at 60 mg/day, and diazepam at 4 mg/day, along with twice-monthly ketamine (60 mg) drip infusions. The patient underwent motor cortex stimulation (MCS), resulting in À60% pain relief, reduction in the required doses of pain medications, and discontinuation of ketamine administration. MCS is effective for MS-related neuropathic facial pain.

show abstract

Motor Cortex Stimulation as Treatment of Trigeminal Neuropathic Pain

Cited by 149 publications

References 8 publications

Motor Cortex Stimulation for Pain and Movement Disorders

Motor Cortex Stimulation for Pain and Movement Disorders

Nichtmanuelle Schmerztherapie der Lenden-Becken-Hüft-Region

Motor Cortex Stimulation for Intractable Neuropathic Facial Pain Related to Multiple Sclerosis -Case Report-

Contact Info

Product

Resources

About